Lisette Del Corso

Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC

Manlio Mencoboni, Rosangela Filiberti, Paola Taveggia et al. · Anticancer Research · 2017 · 25 citations · Full text

Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes

Enrico Balleari, Chiara Salvetti, Lisette Del Corso et al. · Leukemia Research · 2015 · 23 citations

Hematological Malignancy, Bone Marrow Failure, Aplastic Anemia +7

Is Soluble Mesothelin-Related Protein an Upfront Predictive Marker of Pleural Mesothelioma? A Prospective Study on Italian Workers Exposed to Asbestos

Rosangela Filiberti, Paola Marroni, Fabio Spigno et al. · Oncology · 2013 · 20 citations

Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes

Enrico Balleari, Marino Clavio, Eleonora Arboscello et al. · Leukemia Research · 2011 · 19 citations

Hematological Malignancy, Thrombosis, Bone Marrow Failure +9

Cardiovascular adverse events complicating the administration of rituximab: report of two cases.

Caterina Passalia, Paola Minetto, Eleonora Arboscello et al. · PubMed · 2014 · 15 citations

Cardiovascular Toxicity, Thrombosis, Lymphoid Neoplasia +14